Prospective risk analysis in a retrocession unit: Focus on drug dispensation process

被引:6
作者
Darcissac, C. [1 ]
Duvert, L. [1 ]
Hoegy, D. [1 ,2 ,3 ]
Chappuy, M. [1 ]
Pivot, C. [1 ]
Janoly-Dumenil, A. [1 ,2 ,3 ]
机构
[1] Hosp Civils Lyon, Pharm Hop Edouard Herriot, 5 Pl Arsonval, F-69003 Lyon, France
[2] Univ Claude Bernard Lyon 1, 6 Ave Rockefeller, F-69008 Lyon, France
[3] Fac Med Laennec, EA Parcours Sante Syst 4129, 7-11 Rue Guillaume Paradin, F-69372 Lyon 08, France
来源
ANNALES PHARMACEUTIQUES FRANCAISES | 2020年 / 78卷 / 01期
关键词
FMEA; Failure mode effect analysis; Criticity; Drug dispensing; Management tool; FAILURE MODE; SAFETY; CARE; IMPROVE;
D O I
10.1016/j.pharma.2019.06.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives. - Failure mode effect analysis (FMEA) improves safety in the drug life cycle. As the drug dispensation by hospital's pharmacy can be at risk, the FMEA tool has been used to evaluate and enhance the process. Methods. - After detailing the process, a first FMEA has been run in 2015. Corrective actions were implemented every time criticality indexes (CI) were above 15. One year later, we have evaluated potential impacts of these actions by running a new FMEA. Results. - In 2015, 11 failure modes were prioritized (CI > 15) and the total CI for the overall process was 397. Corrective actions were implemented and one year later this amount has decreased by 14% (340) with 6 failure modes still prioritized. Thus, thanks to the FMEA, risks could be identified in year "y", they were taken into account and corrected and then effectively reassessed in year "y + 1". Conclusion. - This study showed us the interest of performing FMEA analysis in the drug dispensation process by hospital. The renewal of this risk analysis after a year helped us to monitor corrective actions, to evaluate their effectiveness and to improve safety. Finally, FMEA seems to be an effective way to steer the drug dispensation process. (C) 2019 Academie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 28 条
[1]  
ARS Nouvelte-Aquitaine, 2016, SEC OFF AD DEM QUAL
[2]  
Baussand V, 1999, REFLEXIONS CONFIDENT
[3]  
Begaud B., 2013, Rapport sur la surveillance et la promotion du bon usage du medicament en France
[4]   Failure mode and effects analysis (FMEA) of insulin in a mother-child university-affiliated health center [J].
Berruyer, M. ;
Atkinson, S. ;
Lebel, D. ;
Bussieres, J. -F. .
ARCHIVES DE PEDIATRIE, 2016, 23 (01) :1-8
[5]   Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process [J].
Bonnabry, P ;
Cingria, L ;
Ackermann, M ;
Sadeghipour, F ;
Bigler, L ;
Mach, N .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2006, 18 (01) :9-16
[6]   Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions [J].
Bonnabry, P ;
Cingria, L ;
Sadeghipour, F ;
Ing, H ;
Fonzo-Christe, C ;
Pfister, RE .
QUALITY & SAFETY IN HEALTH CARE, 2005, 14 (02) :93-98
[7]   A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety [J].
Bonnabry, Pascal ;
Despont-Gros, Christelle ;
Grauser, Damien ;
Casez, Pierre ;
Despond, Magali ;
Pucin, Deborah ;
Rivara-Mangeat, Claire ;
Koch, Magali ;
Vial, Martine ;
Iten, Anne ;
Lovis, Christian .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2008, 15 (04) :453-460
[8]  
Boule M, 2018, Pharm Hosp Clin, V53, P315
[9]  
Chappuy M., 2015, Annales Pharmaceutiques Francaises, V73, P297, DOI 10.1016/j.pharma.2014.11.001
[10]   Using Failure Mode Effects and Criticality Analysis for High-Risk Processes at Three Community Hospitals [J].
Coles, Garill ;
Fuller, Becky ;
Nordquist, Kathleen ;
Kongslie, Anita .
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2005, 31 (03) :132-140